Results 141 to 150 of about 289,373 (313)

Angiographic predictors of recurrence of restenosis after Wiktor stent implantation in native coronary arteries [PDF]

, 1993
P.P.T. deJaegere, Patrick W. Serruys, Michel E. Bertrand, V. Wiegand, J. Marquis, Matthias Vrolicx, Jan Piessens, B Valeix, Gisbert Kober, Hans R. Bonnier, Wolfgang Rutsch, R. Uebis   +11 more
openalex   +1 more source

Implantable Medical Devices, Biomaterials, and the Foreign Body Response: A Surgical Perspective

Journal of Biomedical Materials Research Part A, Volume 113, Issue 9, September 2025.
ABSTRACT Implantable medical devices improve quality of life and reduce mortality by restoring the form and function of the human body. Their biomaterial surface components in contact with tissues are, however, susceptible to the host's foreign body response, which drives inflammation and implant fibrous encapsulation.
Nikita Kalashnikov, Jake Barralet, Joshua Vorstenbosch   +2 more
wiley   +1 more source

Lesion-to-lesion independence of restenosis after treatment by conventional angioplasty, stenting, or directional atherectomy. Validation of lesion-based restenosis analysis. [PDF]

, 1993
C. Michael Gibson, Richard E. Kuntz, M Nobuyoshi, Bernard Rosner, Donald S. Baim   +4 more
openalex   +1 more source

Cilostazol reduces restenosis after carotid artery stenting [PDF]

, 2010
BACKGROUND: Although carotid artery stenting (CAS) has been proposed as an alternative to carotid endarterectomy in cerebral revascularization, restenosis remains an unsolved issue.
Hayakawa Mikito, Matsumaru Yuji, Matsumura Akira, Nemoto Shigeru, Takigawa Tomoji, 松村 明, 滝川 知司   +6 more
core   +1 more source

Stent placement for renal arterial stenosis: where do we stand? A meta-analysis [PDF]

, 2000
PURPOSE: To perform a meta-analysis of renal arterial stent placement in comparison with renal percutaneous transluminal angioplasty (PTA) in patients with renal arterial stenosis.
Bosch, J.L. (Johanna), Deinum, J. (Jacob), Dijk, L.C. (Lukas) van, Gussenhoven, E.J. (Elma), Jaarsveld, B.C. (Brigit) van, Leertouwer, T.C. (Trude), Man in 't Veld, A.J. (Arie)   +6 more
core   +1 more source

Early Lumen Loss After Treatment of In-Stent Restenosis [PDF]

, 1998
Avinoam Shiran, Gary S. Mintz, Ron Waksman, Roxana Mehran, Alexandre Abizaid, Kenneth M. Kent, Augusto D. Pichard, Lowell F. Satler, Jeffrey J. Popma, Martin B. Leon   +9 more
openalex   +1 more source

Recurrent intra-stent coronary restenosis in a carrier of non-disease-specific antinuclear antibodies

European Journal of Case Reports in Internal Medicine
Intracoronary in-stent restenosis (ISR) is a phenomenon that generally occurs between 3 and 6 months after stent placement. With the introduction of drug-eluting stents (DES), the incidence of ISR has decreased but not disappeared.
Benedetta Tomberli, Stefano Fumagalli, Tiziana Cristina Minopoli, Silvia Menale, Valentina Scheggi, Niccolò Marchionni   +5 more
doaj   +1 more source

Assessment of Plaque Characteristics by Contrast-Enhanced Ultrasound and Stent Restenosis following Carotid Artery Stenting: A Retrospective Study

Medicina
Background and objective: carotid artery stenosis contributes significantly to ischemic strokes, with management options including carotid endarterectomy (CEA) and carotid artery stenting (CAS) ischemic stroke risk can be reduced.
Agnė Gimžauskaitė, Donatas Inčiūra, Gintautė Diringytė, Saulius Lukoševičius, Rytis Kaupas, Andrius Pranculis, Aistė Mačiulaitytė, Algidas Basevičius, Milda Kuprytė, Edgaras Stankevičius, Jurgita Plisienė   +10 more
doaj   +1 more source

Unusual Response of Subclavian In-Stent Restenosis to Balloon Angioplasty in a Patient with HIV

Case Reports in Vascular Medicine, 2015
Human Immunodeficiency Virus (HIV) infection and use of protease inhibitors have been associated with accelerated atherosclerosis. Increased rates of coronary in-stent restenosis are reported in these patients.
Mohammad Atif Rana, Jagan Beedupalli, Nuri I. Akkus   +2 more
doaj   +1 more source

Development of coronary stents using advanced results of materials science and technology [PDF]

, 2004
Stents are high tech endovascular implants. K&M Inc. is the single Eastern European stent producer company. The market needs more biocompatible devices as the trend of the stent development all the producers have to react.
Dobránszky, János, Major, L., Nyitrai, Zs., Puskás, Zs.   +3 more
core